Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Report 2020
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
The production mainly distributed in two regions of USA: Puerto Rico (83%), Massachusetts (17%). Medtronic is the manufacturing giants in this field, taking about 83% of the USA production. Medtronic is the largest player with 83% production market, followed by Codman & Shurtleff (J&J) with 15% in 2015.
USA implantable infusion pumps consumption increased from 23.71 K units in 2011 to 28.69 K units in 2015, with an average growth rate of 3.85%. Cancer Treatment and chronic pain treatment are the major fields where implantable infusion pumps are frequently used. In 2015, 18.14 K units’ implantable infusion pumps were used to relieve the pain of Cancer, accounting for 66.6% of the USA total consumption. 26% of implantable infusion pumps were used for chronic pain treatment.
With fast technology development and strong demand, implantable infusion pumps price kept relatively stable and changed from 9964 USD/Unit in 2011 to 9456 USD/Unit in 2015.
It is expected that the USA implantable infusion pumps comsumption will be 35 K Units in 2021 and the production revenue will reach 311 million USD. At the same time, the price may gradually decline. This industry is easily affected by the technological innovation and the policy.
Market Analysis and Insights: Global Neuromodulation Devices and Implantable Infusion Pumps Market
The global Neuromodulation Devices and Implantable Infusion Pumps market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Neuromodulation Devices and Implantable Infusion Pumps Scope and Market Size
The global Neuromodulation Devices and Implantable Infusion Pumps market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuromodulation Devices and Implantable Infusion Pumps market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Neuromodulation Devices and Implantable Infusion Pumps market is segmented into
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Segment by Application, the Neuromodulation Devices and Implantable Infusion Pumps market is segmented into
Parkinson's disease
Epilepsy
Pain
Other
The Neuromodulation Devices and Implantable Infusion Pumps market is analysed and market size information is provided by regions (countries). Segment by Application, the Neuromodulation Devices and Implantable Infusion Pumps market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Neuromodulation Devices and Implantable Infusion Pumps market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neuromodulation Devices and Implantable Infusion Pumps business, the date to enter into the Neuromodulation Devices and Implantable Infusion Pumps market, Neuromodulation Devices and Implantable Infusion Pumps product introduction, recent developments, etc.
The major vendors covered:
Medtronic
Boston Scientific Corporation
Abbott
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
The production mainly distributed in two regions of USA: Puerto Rico (83%), Massachusetts (17%). Medtronic is the manufacturing giants in this field, taking about 83% of the USA production. Medtronic is the largest player with 83% production market, followed by Codman & Shurtleff (J&J) with 15% in 2015.
USA implantable infusion pumps consumption increased from 23.71 K units in 2011 to 28.69 K units in 2015, with an average growth rate of 3.85%. Cancer Treatment and chronic pain treatment are the major fields where implantable infusion pumps are frequently used. In 2015, 18.14 K units’ implantable infusion pumps were used to relieve the pain of Cancer, accounting for 66.6% of the USA total consumption. 26% of implantable infusion pumps were used for chronic pain treatment.
With fast technology development and strong demand, implantable infusion pumps price kept relatively stable and changed from 9964 USD/Unit in 2011 to 9456 USD/Unit in 2015.
It is expected that the USA implantable infusion pumps comsumption will be 35 K Units in 2021 and the production revenue will reach 311 million USD. At the same time, the price may gradually decline. This industry is easily affected by the technological innovation and the policy.
Market Analysis and Insights: Global Neuromodulation Devices and Implantable Infusion Pumps Market
The global Neuromodulation Devices and Implantable Infusion Pumps market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Neuromodulation Devices and Implantable Infusion Pumps Scope and Market Size
The global Neuromodulation Devices and Implantable Infusion Pumps market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuromodulation Devices and Implantable Infusion Pumps market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Neuromodulation Devices and Implantable Infusion Pumps market is segmented into
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Segment by Application, the Neuromodulation Devices and Implantable Infusion Pumps market is segmented into
Parkinson's disease
Epilepsy
Pain
Other
The Neuromodulation Devices and Implantable Infusion Pumps market is analysed and market size information is provided by regions (countries). Segment by Application, the Neuromodulation Devices and Implantable Infusion Pumps market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape
and Neuromodulation Devices and Implantable Infusion Pumps Market Share AnalysisNeuromodulation Devices and Implantable Infusion Pumps market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neuromodulation Devices and Implantable Infusion Pumps business, the date to enter into the Neuromodulation Devices and Implantable Infusion Pumps market, Neuromodulation Devices and Implantable Infusion Pumps product introduction, recent developments, etc.
The major vendors covered:
Medtronic
Boston Scientific Corporation
Abbott
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
